www.medical-devices.tech
04
'25
Written on Modified on
GE HealthCare and AliveCor technologies to enhance cardiac care
Hannover Medical School pioneers integrating hospital systems with a home ECG device, enabling remote cardiac monitoring and faster clinical decisions for better patient care.
www.gehealthcare.com
GE HealthCare and AliveCor announced the world’s first clinical go-live of the integration between GE HealthCare’s MUSE™ Cardiology Information System and AliveCor’s KardiaMobile® 6L electrocardiogram (ECG) device at Hannover Medical School (MHH), Germany. The collaboration aims to optimize patient care and reduce hospitalizations linked to cardiac events by expanding care outside the hospital with remote patient monitoring.
Patients can use KardiaMobile 6L to record medical-grade single-lead and six-lead ECGs from home or other remote locations, aiming to reduce the need for in-person hospital or clinic visits. Through this clinical integration by MHH, these recordings are securely and seamlessly integrated into the hospital’s existing workflow through GE HealthCare’s MUSE Cardiology Information System. MHH physicians are able to access, evaluate, and compare KardiaMobile 6L ECGs and in-hospital and clinic ECGs in near real time, supporting faster clinical decision-making and continuity of care, while also giving patients peace of mind that their physicians may have the opportunity to review their ECGs promptly.
With MUSE, ECGs acquired using KardiaMobile 6L are automatically routed into the electronic medical record at MHH, eliminating manual data entry and supporting efficiency gains. One study found that using KardiaMobile for remote patient monitoring reduces the need for in-person ECGs and other cardiac assessments, enabling clinicians to deliver care more efficiently without adding to their workload.
KardiaMobile 6L is clinically validated to detect atrial fibrillation, and other arrhythmias - conditions associated with significant hospitalizations and mortality worldwide. Atrial fibrillation is now the most common sustained cardiac arrhythmia in Europe, affecting over 11 million people and contributing to 8.4 million disability-adjusted life years (DALYs) globally. By enabling patients to capture medical-grade ECGs from home or remote locations, the integration expands access to diagnostic data, supports decentralized care models, and may help reduce avoidable hospital visits.
The collaboration between GE HealthCare, Hannover Medical School and AliveCor underscores a shared commitment to advancing connected, patient-centric cardiac care. By combining mobility, precision, and interoperability, the collaboration helps clinicians deliver more timely, informed, and coordinated care.
www.gehealthcare.com
Patients can use KardiaMobile 6L to record medical-grade single-lead and six-lead ECGs from home or other remote locations, aiming to reduce the need for in-person hospital or clinic visits. Through this clinical integration by MHH, these recordings are securely and seamlessly integrated into the hospital’s existing workflow through GE HealthCare’s MUSE Cardiology Information System. MHH physicians are able to access, evaluate, and compare KardiaMobile 6L ECGs and in-hospital and clinic ECGs in near real time, supporting faster clinical decision-making and continuity of care, while also giving patients peace of mind that their physicians may have the opportunity to review their ECGs promptly.
With MUSE, ECGs acquired using KardiaMobile 6L are automatically routed into the electronic medical record at MHH, eliminating manual data entry and supporting efficiency gains. One study found that using KardiaMobile for remote patient monitoring reduces the need for in-person ECGs and other cardiac assessments, enabling clinicians to deliver care more efficiently without adding to their workload.
KardiaMobile 6L is clinically validated to detect atrial fibrillation, and other arrhythmias - conditions associated with significant hospitalizations and mortality worldwide. Atrial fibrillation is now the most common sustained cardiac arrhythmia in Europe, affecting over 11 million people and contributing to 8.4 million disability-adjusted life years (DALYs) globally. By enabling patients to capture medical-grade ECGs from home or remote locations, the integration expands access to diagnostic data, supports decentralized care models, and may help reduce avoidable hospital visits.
The collaboration between GE HealthCare, Hannover Medical School and AliveCor underscores a shared commitment to advancing connected, patient-centric cardiac care. By combining mobility, precision, and interoperability, the collaboration helps clinicians deliver more timely, informed, and coordinated care.
www.gehealthcare.com
